4.25
+0.27(+6.78%)
Currency In USD
| Previous Close | 3.98 |
| Open | 3.99 |
| Day High | 4.49 |
| Day Low | 3.9 |
| 52-Week High | 5.54 |
| 52-Week Low | 2.32 |
| Volume | 3.05M |
| Average Volume | 1.16M |
| Market Cap | 254.5M |
| PE | 6.54 |
| EPS | 0.65 |
| Moving Average 50 Days | 2.8 |
| Moving Average 200 Days | 3.28 |
| Change | 0.27 |
If you invested $1000 in Eledon Pharmaceuticals, Inc. (ELDN) 10 years ago, it would be worth $2.37 as of October 30, 2025 at a share price of $4.25. Whereas If you bought $1000 worth of Eledon Pharmaceuticals, Inc. (ELDN) shares 5 years ago, it would be worth $162.34 as of October 30, 2025 at a share price of $4.25.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Eledon Pharmaceuticals to Present Results from Phase 2 BESTOW Trial of Tegoprubart for the Prevention of Rejection in Kidney Transplantation at the American Society of Nephrology Kidney Week 2025 Annual Meeting
GlobeNewswire Inc.
Oct 17, 2025 11:00 AM GMT
Conference call and webcast to discuss results to be held on November 7, 2025 at 8:00 a.m. ETIRVINE, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced an oral presentation will be featu
Eledon Pharmaceuticals to Present at the 18th Congress of the International Xenotransplantation Association
GlobeNewswire Inc.
Sep 24, 2025 8:05 PM GMT
IRVINE, Calif., Sept. 24, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that Steve Perrin, Ph.D., President and Chief Scientific Officer, will participate in a plenary session at the upcoming 18th C
Eledon Pharmaceuticals to Participate in Cantor Global Healthcare Conference 2025
GlobeNewswire Inc.
Aug 29, 2025 11:00 AM GMT
IRVINE, Calif., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that David-Alexandre C. Gros, M.D., Chief Executive Officer, will participate in a fireside chat at the upcoming Cantor Global